Advanced Radiotherapy is a game-changer for India's cancer care burden
Nov 27, 2025
Mumbai (Maharashtra) [India], November 27: In a country with over 1.4 million[i] cases reported annually, with most being reported at later stages, adaptive radiotherapy (ART) is a major benefit to India's ever-growing cancer burden. ART not only has the possibility to improve survival rates, but it also will enhance the overall quality of life for patients. It has become a critical tool for cancer treatment and management as it allows real-time precision therapy - making personalized treatment a reality. To further strengthen India's fight against cancer, Elekta, a global leader in precision radiation therapy will introduce Elekta Evo, an advanced AI-enabled CT-Linac (linear accelerator). This launch will be held during the Association of Radiation Oncologists of India conference (AROICON) at Biswa Bangla Convention Centre, Kolkata, from November 28-30, 2025.